These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Loftsson T; Bodor N Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460 [TBL] [Abstract][Full Text] [Related]
5. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin. Kata M; Lukács M Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397 [No Abstract] [Full Text] [Related]
6. Enhancement of solubility of furosemide with beta-cyclodextrin. Kata M; Antal A Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396 [No Abstract] [Full Text] [Related]
7. Study of products containing mebendazole and beta-cyclodextrin. Kata M; Papp L Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409 [No Abstract] [Full Text] [Related]
8. Production and investigating of tablets containing furosemide and beta-cyclodextrin. Kata M; Haragh L; Pintye-Hódi K Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256 [TBL] [Abstract][Full Text] [Related]
9. [Application of beta-cyclodextrin during direct pressing of tablets]. Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849 [TBL] [Abstract][Full Text] [Related]
10. [Spray embedding of vinpocetin with beta-cyclodextrin]. Kata M; György E Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372 [No Abstract] [Full Text] [Related]
12. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories]. Tóth K; Apostol I Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726 [No Abstract] [Full Text] [Related]
13. [Molecular cavity filling and tabletting with beta-cyclodextrin]. Hüttenrauch R; Fricke S Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643 [No Abstract] [Full Text] [Related]
14. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories]. Gyulai M; Apostol I Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724 [No Abstract] [Full Text] [Related]
15. [Inclusion compounds of 8 Chinese medicinal volatile oils with beta-cyclodextrin]. Li SZ; Guan SJ Zhong Yao Tong Bao; 1987 Dec; 12(12):27-32, 58-9. PubMed ID: 3446391 [No Abstract] [Full Text] [Related]
16. [Use of beta-cyclodextrin on the pharmaceutics of a volatile oil from a Chinese medicine: 2 inclusion methods]. Li SZ Zhong Yao Tong Bao; 1986 Dec; 11(12):31-3. PubMed ID: 2952338 [No Abstract] [Full Text] [Related]
17. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex]. Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810 [No Abstract] [Full Text] [Related]
18. [Preparation and investigation of products containing metronidazole and beta-cyclodextrin]. Kata M; Antal A Acta Pharm Hung; 1984 May; 54(3):116-22. PubMed ID: 6464773 [No Abstract] [Full Text] [Related]
19. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution. Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072 [No Abstract] [Full Text] [Related]
20. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin. Kata M; Tüske B Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309 [No Abstract] [Full Text] [Related] [Next] [New Search]